176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
42.20%
Cash & equivalents yoy growth at least 1.5x AVGO's 25.39%. Mohnish Pabrai might see this as a favorable liquidity edge, provided funds are well deployed.
85900.00%
Higher Short-Term Investments Growth compared to AVGO's zero value, indicating better performance.
50.08%
Cash + STI yoy ≥ 1.5x AVGO's 25.39%. David Dodd might see it as a strategic cash buffer advantage. Evaluate deployment plans.
15.09%
Receivables growth above 1.5x AVGO's 9.88%. Michael Burry would check for potential credit bubble or inflated top-line.
15.22%
Inventory growth below half of AVGO's -5.08%. David Dodd would check if that's due to efficiency or supply constraints.
24.20%
Similar to AVGO's 30.19%. Walter Schloss would confirm standard short-term asset patterns.
43.05%
≥ 1.5x AVGO's 20.22%. David Dodd might see a short-term liquidity advantage or potential underutilized capital.
0.79%
Below half AVGO's -0.52%. Michael Burry sees potential underinvestment risk unless there's a valid reason (asset-light model).
1.62%
Above 1.5x AVGO's 0.02%. Michael Burry warns of potential big write-downs if synergy fails.
63.27%
Less than half of AVGO's -8.12%. David Dodd sees relatively fewer intangible expansions. Possibly more tangible-driven.
6.15%
Less than half of AVGO's -2.25%. David Dodd sees fewer intangible expansions vs. competitor. Possibly safer balance sheet.
-100.00%
Both AVGO and the company show zero Long-Term Investments Growth.
-2.74%
Higher Tax Assets Growth compared to AVGO's zero value, indicating worse performance.
190.24%
Higher Other Non-Current Assets Growth compared to AVGO's zero value, indicating worse performance.
1.24%
Below half of AVGO's -2.13%. Michael Burry might suspect stagnation or lack of resources for expansions.
No Data
No Data available this quarter, please select a different quarter.
34.30%
≥ 1.5x AVGO's 1.37%. David Dodd notes a larger balance sheet expansion. Confirm it's not overleveraged.
10.77%
1.25-1.5x AVGO's 7.42%. Martin Whitman sees potential reliance on supplier financing. Verify liquidity.
No Data
No Data available this quarter, please select a different quarter.
21.31%
Similar yoy tax payables growth to AVGO's 27.73%. Walter Schloss sees no major difference in near-term tax obligations.
23.40%
1.25-1.5x AVGO's 18.24%. Bruce Berkowitz checks if there's a competitive advantage in forward billing.
1.78%
Less than half of AVGO's -52.79%. David Dodd sees fewer expansions in other current obligations.
6.67%
1.25-1.5x AVGO's 5.07%. Martin Whitman is wary of bigger short-term burdens.
193.03%
Above 1.5x AVGO's 2.07%. Michael Burry suspects significant leverage additions. Check coverage.
11.67%
Below half AVGO's -10.69%. Michael Burry suspects a serious gap in multi-year pipeline.
10.34%
Similar yoy changes to AVGO's 10.69%. Walter Schloss sees parallel tax deferral patterns.
24.80%
Above 1.5x AVGO's 11.12%. Michael Burry suspects a looming risk from large additions to LT liabilities.
148.03%
Above 1.5x AVGO's 1.35%. Michael Burry sees a strong spike vs. competitor. Check coverage and debt ratios.
No Data
No Data available this quarter, please select a different quarter.
98.69%
Above 1.5x AVGO's 1.81%. Michael Burry sees a potential leverage warning sign.
No Data
No Data available this quarter, please select a different quarter.
5.47%
Higher Retained Earnings Growth compared to AVGO's zero value, indicating better performance.
-1100.00%
Less than half of AVGO's 0.93%. David Dodd sees fewer intangible or market-driven swings than competitor.
No Data
No Data available this quarter, please select a different quarter.
7.33%
≥ 1.5x AVGO's 0.41%. David Dodd sees stronger capital base growth than competitor.
34.30%
≥ 1.5x AVGO's 1.37%. David Dodd sees faster overall balance sheet growth than competitor.
85900.00%
Higher Total Investments Growth compared to AVGO's zero value, indicating better performance.
196.94%
Above 1.5x AVGO's 2.12%. Michael Burry sees a major jump. Investigate leverage rationale.
5.13%
Less than half of AVGO's -3.18%. David Dodd sees better deleveraging or stronger cash buildup than competitor.